.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma layer, usin...
.Achilles Rehabs has actually torn up its own method. The English biotech is actually knocking off o...
.Aligos Therapies is advertising a midstage succeed in metabolic-dysfunction associated steatohepati...
.Basilea Pharmaceutica's work cultivating new antifungals has gotten a significant increase coming f...
.Having already gathered up the U.S. rights to Capricor Therapies' late-stage Duchenne muscular dyst...
.After pushing back the decision date for Applied Rehabs' metabolic problem medication govorestat, t...
.Novo Nordisk is actually proceeding its own push in to hereditary medicines, accepting to pay NanoV...
.Innovent Biologics has produced the scenario that its own checkpoint inhibitor-cytokine blend prote...
.A stage 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) h...
.Five months after Rakovina Therapeutics turned toward artificial intelligence, the cancer-focused b...